Relationship between body mass index and 1 mg dexamethasone suppression test in patients with obesity
These findings emphasize that elevated post-dexamethasone cortisol levels in patients with obesity should not be attributed to body weight alone but warrant appropriate evaluation for true hypercortisolism, with clinical interpretation guided by metabolic phenotype rather than BMI.
Authors
- Beril Turan Erdoğan (ORCID: https://orcid.org/0000-0003-1391-0647)
- Bekir Çakır (ORCID: https://orcid.org/0000-0001-7526-8827)
- Cevdet Coşkun AYDIN (ORCID: https://orcid.org/0000-0003-2064-6936)
- Oya Topaloğlu (ORCID: https://orcid.org/0000-0003-2501-935X)
- Ekin Yiğit Köroğlu (ORCID: https://orcid.org/0000-0003-3895-5817)
- Muhammed Sacıkara
- Fatma Neslihan Çuhacı Seyrek
- Reyhan Ersoy
Institutions
- Bilkent University (TR)
- Memorial Ankara Hospital (TR)
- Başkent University Hospital (TR)
- Ankara Yıldırım Beyazıt University (TR)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1111/dom.70522
- Primary Topic
- Adrenal Hormones and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00